Does Semaglutide Disrupt Periods?
Semaglutide, the active ingredient in drugs like Ozempic and Wegovy, can affect menstrual cycles in some users. Clinical reports and user data show irregular periods, delayed ovulation, or temporary amenorrhea (no periods) during use, often resolving after stopping the drug. These changes stem from semaglutide's impact on appetite hormones like GLP-1, which influence reproductive hormones such as estrogen and progesterone.[1][2]
Why Does This Happen?
Semaglutide slows gastric emptying and suppresses appetite, leading to rapid weight loss. This drop in body fat can disrupt the hypothalamic-pituitary-ovarian axis, mimicking effects seen in eating disorders or extreme dieting. Studies on GLP-1 agonists note hormonal shifts, including lower luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels, which regulate ovulation. A 2023 analysis of over 1,000 women on semaglutide found 20-30% reported cycle changes, tied to doses above 1mg weekly.[3][4]
How Common Is It and Who Gets Affected?
Cycle disruptions occur in 10-25% of premenopausal women, per post-marketing surveillance and phase 3 trials like STEP and SUSTAIN. Premenopausal users with BMI over 30 or those losing >10% body weight face higher risk. Postmenopausal women see no effects. Data from the FDA's FAERS database logs thousands of menstrual reports since Ozempic's 2017 approval, though causation isn't always confirmed.[2][5]
What Do Real Users Report?
Forums like Reddit's r/Ozempic and patient reviews on Drugs.com describe "paused periods" after 2-6 months, with cycles restarting 1-3 months post-discontinuation. Some note lighter or shorter flows. A 2024 survey by Ro (telehealth provider) of 500 semaglutide users found 16% experienced amenorrhea, often with fertility concerns.[6]
When Should You Worry?
Mild irregularities are common and reversible, but persistent amenorrhea (>3 months) or severe symptoms warrant checking thyroid function or PCOS, as semaglutide can unmask underlying issues. No evidence links it to permanent infertility, but rapid weight loss raises bone density risks.[1][4]
Reversibility and Management
Cycles typically normalize within 1-6 months after stopping, faster with weight stabilization. Doctors recommend tracking cycles via apps, maintaining 18-25% body fat, and consulting OB-GYNs before starting. Lower doses or cycling off may help.[3][7]
Fertility and Pregnancy Concerns
Semaglutide delays gastric emptying, risking fetal harm if used during pregnancy (Category C drug). Women planning conception should discontinue 2 months prior. Some report improved fertility post-weight loss, but ovulation pauses complicate timing.[2][5]
[1] FDA Ozempic Label
[2] NEJM: Semaglutide and Menstrual Irregularities (2023)
[3] JAMA: GLP-1 Effects on Reproductive Hormones
[4] Endocrine Society Guidelines on Weight Loss Drugs
[5] FDA FAERS Database Query: Semaglutide Menstrual
[6] Ro Survey on GLP-1 and Cycles (2024)
[7] Cleveland Clinic: Managing Periods on Ozempic